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Protein-dissectionforming protein-toxin and a potential virulence factor of Escherichia coli, exhibits
cytotoxic activity to mammalian cells. However, very little is known about how the different individual
segments contribute in the toxic activity of the protein. Toward this end, the role of a 33-residue segment
comprising the amino acid region 88 to 120, which contains the putative transmembrane domain in the tail
region of HlyE has been addressed in the toxic activity of the protein-toxin by characterizing the related wild
type and mutant peptides and the whole protein. Along with the 33-residue wild type peptide, H-88, two
mutants of the same size were synthesized; in one mutant a conserved valine at 89th position was replaced
by aspartic acid and in the other both glycine and valine at the 88th and 89th positions were substituted by
aspartic acid residues. These mutations were also incorporated in the whole toxin HlyE. Results showed that
only H-88 but not its mutants permeabilized both lipid vesicles and human red blood cells (hRBCs).
Interestingly, while H-88 exhibited a moderate lytic activity to human red blood cells, the mutants were not
active. Drastic reduction in the depolarization of hRBCs and hemolytic activity of the whole toxin HlyE was
also observed as a result of the same double and single amino acid substitution in it. The results indicate an
important role of the amino acid segment 88–120, containing the putative transmembrane domain of the tail
region of the toxin in the toxic activity of hemolysin E.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Gram-negative bacteria often produce a variety of cytolytic toxins,
which enable the microorganisms to successfully infect the host
including humans and other animals [1–3]. However, the exact mode
of actions and involvement of the majority of these cytolytic toxins in
the pathogenesis of infections are not clearly understood. A number of
cytolysins isolated from gram-negative bacteria form pores in the
cytoplasmic membranes of eukaryotic cells [4,5]. Disease causing
strains of Escherichia coli (E. coli) produce several pore-forming toxins.
Of these, α-hemolysin (HlyA) is found in E. coli strains, which cause
extra-intestinal infections, while enterohemorrhagic E. coli (EHEC)nol; NBD-ﬂuoride, 4-ﬂuoro-7-
ine; PC, Egg phosphatidylcho-
., amino acid; hRBC, human red
2; fax: +91 522 2623405.
ll rights reserved.hemolysin is produced by EHEC strains of serogroup O157 [2,6]. The
nonpathogenic strain, E. coli K-12, does not contain the gene cluster
required for the production and secretion of α-hemolysin or the
related EHEC hemolysin and is non-hemolytic under normal condi-
tion. However, a variant of E. coli K-12 can also express a hemolytic or
cytolytic phenotype under certain conditions. This induction of
cytolytic activity in the laboratory strain, E. coli K-12 has been
shown to be due to the synthesis of a toxin, named as hemolysin
E (HlyE) or silent hemolysin A (SheA) or cytolysin A (ClyA) by different
groups [7,8]. E. coli, expressing hemolysin E can cause lysis of red
blood cells from different species, including humans, horse, sheep,
goat and hen [8–11]. The expression of hlyE gene in E. coli K-12 is
silenced by the nucleoid protein histone-like nucleoid-structuring
protein (H-NS) [12] while it is activated in the presence of over-
production of SlyA, MprA, HlyX or fumarate and nitrate reduction
regulator (FNR) [8,9,12,13]. The expression of hemolysin E has also
been found in clinical isolates of E. coli [14]. Furthermore, puriﬁed
HlyE and HlyE-expressing E. coli exhibit cytotoxic and apoptogenic
activities towards human and murine macrophages, human
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that hemolysin E after secretion into the periplasm of E. coli, is
packaged in its outer membrane vesicles in the active form and from
there transported into the target mammalian cells [16].
Crystal structure of hemolysin E has been solved at 2.0 Å
resolution, which indicated that it belongs to a new family of toxin
structures [17]. A structure–function study showed that the deletion
of 37 amino acids from the αG region, at the C-terminal of the toxin
rendered it non-hemolytic [18]. An amphipathic, conserved leucine
zipper motif from hemolysin E has been identiﬁed and characterized
[19–21], which suggested a possible structural and functional role of
this motif in the toxin. However, it is still not known how hemolysin E
exhibits cytotoxic activity to eukaryotic cells for example lyses human
red blood cells. The literature shows that for a number of proteins
belonging to several families like transcription factors, fusion proteins
of enveloped virus and pore-forming toxins it has been possible to
identify small segments that show certain activity of the correspond-
ing whole protein. However, for hemolysin E no such segment with
hemolytic activity of the toxin was known.
With a goal to understand the contribution of different conserved
hemolysin E segments to the membrane-interaction and functional
activity of the whole protein, we have synthesized and characterized
a 33-residue peptide (H-88, amino acid 88–120), which contains a
putative transmembrane domain [13,17], located in the tail region of
the protein along with two mutants of the same size. In one of them
(Mu1-H-88), a conserved valine at 89th position was substituted by
an aspartic acid while in the other glycine and valine positioned at
the 88th and 89th positions were replaced by two aspartic acid
residues. The lytic activity of E. coli containing the hemolysin E
plasmid with the latter mutations was signiﬁcantly reduced [9].
Therefore, it was of interest to look into the effect of the same
mutation on the activity of the H-88 segment. In the ﬁrst mutant the
purpose was to look into the effect of the substitution of the single
amino acid positioned in the putative transmembrane segment.
Furthermore, in order to look into the effect of these single and
double amino acid substitutions on the cytotoxic activity of the
whole toxin, site directed mutagenesis was performed in the hlyE
plasmid to prepare both the mutant proteins with the above amino
acid substitutions. The wild type and mutant proteins were puriﬁed
and then characterized along with the synthetic peptides. Results
showed that H-88 permeabilized both phospholipid vesicles and
human red blood cells (hRBCs), and more interestingly lysed them
like the whole protein though with lesser efﬁciency. Although the
amino acid substitutions were done at the N-terminal of the selected
segment, the mutant peptides did not exhibit any appreciable pore-
forming activity in lipid vesicles or hRBCs and showed no lytic
activity toward the hRBCs. Hemolysin E mutants with the same
mutations as in the peptide showed drastically reduced hemolytic
activity and permeabilized the human red blood cells negligibly as
compared to the wild type protein. The results have been discussed
in terms of the plausible role of the H-88 segment containing the
conserved putative transmembrane region in toxic activity of the
protein toxin HlyE.
2. Materials and methods
2.1. Materials
Rink amideMBHA resin (loading capacity, 0.63mmol/g) and all the
N-α Fmoc and necessary side-chain protected amino acids were
purchased from Novabiochem, Switzerland. Coupling reagents for
peptide synthesis like 1-hydroxybenzotriazole (HOBT), di-isopropyl-
carbodiimide (DIC), 1,1,3,3-tetramethyluronium tetraﬂuoroborate
(TBTU) and N, N′-diisopropylethylamine (DIPEA) were purchased
from Sigma, USA. Dichloromethane, N, N′ dimethylformamide (DMF)
and piperidine were of standard grades and procured from reputedlocal companies like Merck Limited, Mumbai, Thomas Baker, Mumbai
and Spectrochem Pvt. Ltd., Mumbai respectively. Acetonitrile (HPLC
grade) was procured from Merck, India while triﬂuoroacetic acid
(TFA), triﬂuoroethanol (TFE) and sodium dodecyl sulfate (SDS) were
purchased from Sigma. Egg phosphatidylcholine (PC) and egg
phosphatidylglycerol (PG) were obtained from Northern Lipids Inc.,
Canada while cholesterol (Chol) was purchased from Sigma. NBD-
ﬂuoride (4-ﬂuoro-7-nitrobenz-2-oxa-1, 3-diazole) and tetramethylr-
hodamine succinimidyl ester were procured from Molecular probes
(Eugene, OR) whereas calcein was purchased from Sigma and used
without any further puriﬁcation. Rests of the reagents were of
analytical grade and procured locally; buffers were prepared in milli
Q water.
2.2. Peptide synthesis, ﬂuorescent labeling and puriﬁcation
All the peptides were synthesized manually on solid phase.
Stepwise solid phase syntheses were carried out on rink amide
MBHA resin (0.15 mmol) utilizing the standard Fmoc chemistry and
employing DIC/HOBTor TBTU/HOBT/DIPEA coupling procedure [22] as
already reported [19,23]. De-protection of α-amino group and the
coupling of amino acids were checked by the Kaiser test [24] for
primary amines. After the synthesis, each peptide was cleaved from
the resinwith simultaneous de-protection of side chains by treatment
with a mixture of TFA/phenol/thioanisole/1,2 ethanedithiol/water
(82.5:5:5:2.5:5 v/v) for 6–7 h. Labeling at the N-terminus of a peptide
with NBD or rhodamine was achieved by standard procedures as
reported [19,25,26]. After sufﬁcient labeling, the resins were washed
with DMF and DCM in order to remove the un-reacted probe. The
peptides were cleaved from the resin as above and precipitated with
dry ether. All the labeled and unlabeled peptides were puriﬁed by
reversed-phase HPLC on an analytical Vydac C4 column using a linear
gradient of 0–80% acetonitrile in 45minwith a ﬂow rate of 0.8ml/min.
Both acetonitrile and water contained 0.05% TFA. The puriﬁed
peptides were ∼95% homogeneous as shown by HPLC. Experimental
mass of the peptides as detected by ES–MS analysis corresponded very
close to their theoretical values.
2.3. Generation of double and point mutation in hlyE
Site directed mutagenesis was done in order to substitute Glycine
at 88th and Valine at 89th position by aspartic acid residues in HlyE.
This was accomplished by introducing mutations in the internal
forward FPIHlymE (5' AT GAA TGG TGT GAT GAT GCG ACG CA 3') and
reverse primer RPIHlymE (5' TG CGT CGC ATC ATC ACA CCA TTC AT 3')
as underlined. The PCR was done using pGS-1111 (construct of pGEX-
KG and hlyE) as the template, which was isolated from the engineered
E. coli JM109 cells (a gift from Prof. Jefrey Green, University of Shefﬁeld,
U.K.) carrying the same plasmid using two sets of primer combina-
tions, forward outer FPOHlymE (5'CCA TGG CTG AAA TCG TTG CAG A
3') and internal reverse RPIHlymE and internal forward FPIHlymE and
outer reverse RPOHlymE (5'GTC GAC TCAGAC TTC AGG TAC CTC AAAG
3'). The ampliﬁed products were gel eluted, quantiﬁed and mixed
together in equal proportion and further used as template to amplify
the full-length hlyE gene using primer set FPOHlymE and RPOHlymE.
The ampliﬁed hlyE was gel eluted and cloned in pDrive (Quiagen PCR
cloning kit), which was subcloned in the expression vector pGEX-KG
at NcoI/SalI site as pDKJ1. The positive clone was sequenced on ABI
sequencer (Supplementary Fig. 1) and aligned with the original hlyE
sequence using Gene Tool software.
The same procedure was followed to introduce the point mutation
to replace valine at 89th position by a single aspartic acid residue as
mentioned above except the internal primers set used for introducing
mutation was replaced by FPIHlymVD (5' AT GAA TGG TGT GGT GAT
GCG ACG CA 3') and RPIHlymVD(5' TG CGT CGC ATC ACC ACA CCA TTC
AT 3'). The mutated gene was subcloned in the expression vector
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Fig. 2) as before.
Chromatograms showing the partial nucleotide sequence of the
Mu1-hlyE and Mu2-hlyE have been presented in Supplementary Fig. 1
and Supplementary Fig. 2 respectively. Crystal structure of HlyE with
segments used in this study marked in different colors has been
shown in Supplementary Fig. 3; while calcein release induced by H-88
and its mutants in PC/PG lipd vesicles has been shown in Supple-
mentary Fig. 4.
2.4. Expression of hemolysin E and its mutants and their puriﬁcation
The mutated plasmids were transformed into E. coli JM109 cells by
a standard procedure. Hemolysin E and its mutants were expressed
and puriﬁed as reported earlier [18,21]. E. coli JM109 cells either
carrying the pGS-1111 plasmid, which contains the expression vector
of GST-hemolysin E or the mutated plasmids for the expression
vectors GST-G88V89DHlyE and GST-V89DHlyE were grown in LB
broth for 3 h at 37 °C before induction of the expression of the fusion
proteins by addition of isopropyl-1-thio-β-D-galactopyranoside
(100 μg/ml). After a further 4 h of incubation at 37 °C bacteria were
collected by centrifugation at 7000 r.p.m at 4 °C. The bacterial pellet
was suspended in 10 mM Tris–HCl, pH 8.0 containing 10 mM
benzamidine and 0.1 mM phenylmethylsulfonyl ﬂuoride. The above
bacterial suspension was then sonicated for the disruption of the
bacterial membrane followed by centrifugation at 12,000 r.p.m at 4 °C.
The supernatant was taken and loaded on a GSH-Sepharose column
equilibrated with 25 mM Tris–HCl, pH 6.8 containing 100 mM NaCl
and 2.5 mM CaCl2. After washing with 10 volumes of the same buffer,
HlyE was released by the thrombin treatment (5 U for 16 h at 25 °C).
Concentrations of the proteins were estimated with the help of the
Lowry method [27].
2.5. Preparation of small unilamellar vesicles (SUVs)
SUVs of either PC/cholesterol (8:1 w/w) or PC/PG (1:1 w/w) were
prepared by a standard procedure [19,28] using a bath-type
sonicator. The lipid concentration was determined by phosphorus
estimation [29].
2.6. Circular dichroism (CD) experiments
The CD spectra of peptides were recorded in 40% TFE (inwater v/v)
and 1% SDS (w/v) by utilizing a Jasco J-810 spectropolarimeter. The
spectropolarimeter was calibrated routinely with 10-camphor sul-
phonic acid. The samples were scanned at room temperature (∼30 °C)
with the help of a capped quartz cuvette of 0.2 cm path length in the
wavelength range of 250–195 nm. An average of 4–6 scans were taken
for each sample with a scan speed of 20 nm/min and data interval of
0.5 nm for peptide concentration of 10–20 μM. The fractional helicities
(Fh) were calculated by a standard formulae as shown below [30,31]
and reported earlier [19,21,23].
Fh =
θ½ 222− θ½ 0222
θ½ 100222− θ½ 0222
where [θ]222 was the experimentally observedmean residue ellipticity
at 222 nm. The values for [θ]100222 and [θ]0222 that correspond to 100
and 0% helix contents were considered to have mean residue
ellipticity values of −32,000 and −2,000 respectively at 222 nm [31].
2.7. Membrane-binding experiments
The afﬁnity of the peptides for phospholipid vesicles was
determined by binding experiments as reported earlier [19,26,32]. In
brief small unilamellar vesicles were added gradually to a freshlydissolved NBD-labeled peptide of 0.2–0.3 μMof concentration at room
temperature. Fluorescence intensities of NBD-labeled peptides alone
and after each addition of lipid vesicles were recorded on a Perkin
Elmer spectroﬂuorimeter, LS-50B, with the excitation and emission
wavelengths set at 467 and 527 nm respectively. The excitation and
emission slits were ﬁxed at 8 and 6 nm respectively. The contributions
of lipid to any of the recorded signal were measured by titrating the
unlabeled peptide (at the concentration of NBD-labeled peptide) with
the same amount of lipid vesicles and were subtracted from the
original ﬂuorescence signal. The binding isotherms were analyzed by
the following equation.
X 4b = K
4
p Cf
where Xb⁎ is deﬁned as the molar ratio of bound peptide per 60% of
the total lipid, assuming that the peptides were initially partitioned
only over the outer leaﬂet of the SUVs as suggested by Beschiaschvili
and Seelig [32]. Kp⁎ represents the partition coefﬁcient and Cf indicates
the concentration of the free peptide at equilibrium.
Xb can be calculated by extrapolating the ﬂuorescence signal
Finﬁnity (ﬂuorescence signal when all the peptide molecules are bound
to lipid) from a double-reciprocal plot of F (peptide ﬂuorescence in the
presence of lipid) versus CL (lipid concentration). Fraction of peptide
bound (fb) was determined by the following equation.
fb = F−F0ð Þ= Finfinity−F0
 
where F is the ﬂuorescence of the peptide when it is bound to lipid
and F0 is the ﬂuorescence of the peptide in its unbound state. When fb
is known, Cf can easily be calculated for each concentration of the
lipid. Kp⁎ can easily be determined from the slope of the plot of Xb⁎
and Cf. Partition coefﬁcient of each of the peptides was determined as
the average of the values obtained from two-three independent
experiments as described previously [19,20].
2.8. Fluorescence resonance energy transfer experiments
Assembly of H-88 and the designed mutants in phospholipid
vesicles was detected with the help of ﬂuorescence energy transfer
experiments using their NBD- and Rho-labeled analogs as energy-
donor and acceptor respectively. The excitation wavelength was set at
467 nm and emission range at 500 to 600 nm. Desired amount of the
NBD-labeled peptide was taken in a ﬂuorimeter cuvette. Sufﬁcient
amount of the phospholipid vesicles ([lipid]/ [peptide]∼2500) were
added to the NBD-labeled peptide to ensure that the peptides were
bound to the membrane. Now the Rho-labeled acceptor peptide was
added to the donor peptide–lipid complex. Energy transfer from the
donor to acceptor was determined by subtracting the acceptor
ﬂuorescence in the presence of lipid and unlabeled donor from the
ﬂuorescence signal obtained in the presence of donor, acceptor and
lipid vesicles.
The efﬁciency of energy transfer (E) was determined by the
decrease in donor's ﬂuorescence in the presence of the acceptor as
reported earlier [19,26,33]. The percentage of energy transfer was
calculated by the following equation.
E = ID0−IDAð Þ=ID0f g×100
where ID0 and IDA are the ﬂuorescence intensities of the NBD-labeled
donor peptide in the absence and presence of the Rho-labeled
acceptor peptide respectively at the emission maxima of the donor
after correcting the light scattering of the lipid vesicles and emission
of the acceptor.
2.9. Detection of pore-forming activity of the peptides in lipid vesicle
Peptide-induced release of calcein from calcein-entrapped lipid
vesicles is often employed to detect the pore-forming activity of
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prepared with a self-quenching concentration (60 mM) of the dye
in 10 mM HEPES at pH 7.4 as reported before [19,34,35]. Peptide-
induced release of calcein from the lipid vesicles was monitored by
the increase in ﬂuorescence due to the dilution of the dye from its
self-quenched concentration. Fluorescence was monitored at room
temperature with excitation and emission wavelengths ﬁxed at 490
and 520 nm respectively. Pore-forming activity of the peptides,
indicated by the calcein release was measured by the ﬂuorescence
recovery as deﬁned by:
Ft = It−I0ð Þ= If −I0
  
×100k
where It= the observed ﬂuorescence after the addition of a peptide at
time t (∼60 s after the addition of the peptide), I0=the ﬂuorescence
before the addition of peptide and If = the total ﬂuorescence, which
was determined after the addition of triton X-100 (0.1% ﬁnal
concentration) to the dye-entrapped vesicle suspension.
2.10. Assay of hemolytic activity of the peptides and proteins
Hemolytic activity of H-88 and its mutants was assayed against
human red blood cells in PBS [9,10,19]. Brieﬂy, fresh human red blood
cells (hRBCs) that were collected in the presence of an anti-coagulant
from a healthy volunteer were washed three times in PBS. Freshly
dissolved peptides in dimethyl sulphoxide (DMSO) at desired
concentrations were added to the suspension of red blood cells
(ﬁnal density∼5×108 cells/ml, counted with help of a LEICA DM 5000
Microscope) in PBS and incubated at 37 °C for 2 h. It is to bementioned
that hemolytic activity of H-88 reached the maximum value at
∼50 min and it remained the same even up to 2 h. The samples were
then centrifuged for 10 min at 2000 r.p.m. and the release of
hemoglobin was monitored by measuring the absorbance (Asample)
of the supernatant at 540 nm. For negative and positive controls hRBC
in PBS (Ablank) and in 0.2% (ﬁnal concentration v/v) Triton X-100
(Atriton) were used respectively. The percentage of hemolysis was
calculated according to the following equation.
Percentageof hemolysis = Asample−Ablank
 
= Atriton−Ablankð Þ
 
×100:
One hemolytic unit was deﬁned as the amount of peptide, which
caused 50% lysis of the hRBCs (∼5×108 cells/ml) after an incubation of
2 h at 37 °C [9].
2.11. Osmotic protection assay
In order to determine the equivalent diameter of the pores
formed by the synthetic putative transmembrane segment on
hRBCs, hemolytic activity of H-88 was examined in the presence
of osmotic protectors as described previously [36,37] with 3% (ﬁnal
concentration, in v/v) hRBCs. Human erythrocytes, prepared in the
same way as the previous experiment were suspended in PBS and
incubated with one of the following osmotic protectors at 30 mM
concentration at 37 °C. Sucrose, rafﬁnose, Poly (ethylene glycol)
(PEG) 1450, PEG 2000, PEG 3000 and PEG 3350 of diameters 0.9,
1.3, 2.2, 2.5, 3.2 and 3.4 nm [36–39] respectively were used in this
experiment as osmotic protectors. After 30 min of incubation to
each of the protector-treated erythrocytes, H-88 was added. H-88
induced hemolysis was determined after another incubation of
50 min at 37 °C by recording the absorbances of the supernatants at
540 nm as the previous experiment. Hemolytic peptides form pores
onto hRBCs, which cause the release of its cytoplasmic contents and
cell death. Osmotic protectors tend to ﬁll this pore and prevent the
release of cytoplasmic content from hRBC. However, to ﬁll the pore
the osmotic protector must have a size comparable to the pore,
which is the basis of osmotic protection assay. Thus when the size
of the osmotic protector matches with the size of pore formed bythe peptides onto the hRBC, inhibition of the hemolytic activity of
the peptides is observed. Accordingly, by observing inhibition of
hemolysis in the presence of osmotic protectors a probable
diameter of the pore formed by a hemolytic peptide onto the
hRBC is determined.
2.12. Human red blood cell membrane depolarization assay
Peptide-induced depolarization of the hRBCs was determined by
its efﬁcacy to dissipate the membrane potential across the hRBCs [40].
Normally a cell is hyperpolarized means it has a potential gradient
across the cell membrane. The potential sensitive dye, DiS-C3-5 tends
to accumulate in hyperpolarized cells, and its ﬂuorescence gets
quenched. Fresh human red blood cells (hRBCs) were collected in the
presence of an anti-coagulant from a healthy volunteer and washed
three times in PBS andwere incubated with diS-C3-5 dye for 1 hwith a
ﬁnal cell density of 0.5×108 cells/ml. When the ﬂuorescence level
(excitation and emission wavelengths were set 620 and 670 nm
respectively) became stable, different amounts of each of the peptides
were added to record the peptide-induced membrane depolarization
of the hRBCs. Peptides capable of forming pores onto hRBC
membranes, depolarize them by dissipation of membrane potential,
which is associated with an increase in ﬂuorescence of the dye.
Membrane depolarization asmeasured by the ﬂuorescence recovery is
deﬁned by the same equation as used to determine the peptide-
induced calcein release, which has been described before already.
However, in this case If, the total ﬂuorescence was determined just
after addition of diS-C3-5 to hRBCs; It, the observed ﬂuorescence after
the addition of a peptide to hRBCs which were already incubated for
1 h with diS-C3-5 dye and I0 is the steady ﬂuorescence level after 1 h
incubation of hRBCs with the dye.
2.13. Detection of damage of hRBC membrane organization in the
presence of the HlyE proteins and H-88 peptides by ﬂow cytometry
Alteration in morphology or organization of the lipid bilayer of
human red blood cells is often probed by annexin V-FITC staining [41].
Therefore, in order to detect any damage of membrane organization of
hRBC in the presence of these peptides and proteins the cells were
stained by annexin V-FITC following the treatment of the cells with
these molecules. Fluorescence of the cells after the treatment the
probe was analyzed by using a Becton Dickinson FACSCalibur ﬂow
cytometer and CellQuest Pro software as reported earlier [21]. The
exitation and emission wavelengths of annexin V-FITC were set at
488 nm and 530 nm respectively.
3. Results
Hemolysin E is a recently identiﬁed pore-forming toxin in E.
coli. Like other pore-forming toxins, [1,2,42] membrane-interaction
and assembly therein are important steps associated with its
function. However, the segment(s) that participates in the interac-
tion with the target cell membrane and contributes to the toxic
activity is not clearly known. In order to evaluate the potential role
of the putative transmembrane segment, located in the tail region
of hemolysin E, a 33-residue peptide comprising the amino acid
region 88–120 was synthesized along with the two mutant
peptides of the same size. Fig. 1A shows the schematic location
of the putative transmembrane domains [13] and two identiﬁed
and partially characterized heptad repeats [19]. Fig. 1B shows the
sequence alignment of the corresponding amino acid region of the
proteins of hemolysin E family, which indicates that a considerable
number of amino acids belonging to all four proteins have identical
sequences. Fig. 1C, depicts the amino acid sequences of the
unlabeled and labeled peptides used in this study. The synthetic
segments that have been employed in this study have been marked
Fig.1. Schematic representation, sequence alignment and amino acid sequences of H-88, its mutants and other peptides used in this study. (A) Schematic representation of hemolysin
E and the localization of H-88 segment in it. The TM1 (putative transmembrane domain 1, a.a. 89–101, [13,17]) and other important segments like the TM2 (a.a.177–203; [17]) and two
heptad repeats at a.a. 130–157 and 205–234 have been shown as marked. (B) Sequence alignment of H-88 (a.a. 88–120) derived from hemolysin E of E. coliwith homologous regions
of hemolysin sequences of avian E. coli (EcAv), Salmonella typhi (Styphi) and Shigella ﬂexneri (Shﬂex). Identical amino acids have been marked as bold letters. (C) Designations and
sequences of the peptides used in this study. The mutated amino acid is marked as underlined.
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PDB) of HlyE (Supplementary Fig. 3).
3.1. Peptides containing the putative transmembrane segment bound to
phospholipid membrane
Since hemolysin E is a pore-forming toxin, it was of interest to
study the membrane-interaction of the peptides that contain the
putative transmembrane domain. In order to study the membrane-
binding ability of these peptides, their NBD-labeled versions and
small unilamellar lipid vesicles (SUV) with different lipid composi-
tion were used. Zwitterionic PC/Chol and negatively charged PC/PG
lipid vesicles are often employed as mimetics of mammalian and
bacterial membrane respectively [33,25,19,23]. The dependence of
NBD-ﬂuorescence on the dielectric constant of the medium has been
employed widely to study the membrane-interaction of proteins and
peptides by attaching the probe onto these molecules [19,26,43,44].
In the presence of either zwitterionic PC/Chol or negatively charged
PC/PG lipid vesicles, emission maxima of NBD-labeled H-88 and
mutant H-88 peptides moved from ∼542 nm to shorter wavelength
(∼527±1.0 nm), concomitant with signiﬁcant increase in ﬂuores-
cence (Fig. 2A). The result indicates the relocation of the probe in the
hydrophobic environment as a result of binding of the peptides to
phospholipid vesicles [19,45]. Fig. 2B shows the plots of ﬂuorescence
of NBD-labeled H-88, Mu1-H-88, Mu2-H-88 with respect to the
lipid/peptide molar ratio when the peptides were treated with
increasing amount of PC/Chol lipid vesicles. NBD-labeled H-88 and
mutants in the presence of increasing PC/PG vesicles showed a
similar extent of ﬂuorescence change and thus exhibited plots of
comparable shapes as that in the presence of PC/Chol vesicles and
therefore not presented. The plots show a gradual increase in NBD-
ﬂuorescence with increase in lipid concentration, indicating the
progressive binding of the NBD-labeled peptide molecules to lipid
vesicles.Binding isotherms (Fig. 2C) were generated by plotting Xb⁎ with
respect to Cf as has been described in the experimental section and
also reported earlier [19]. Partition coefﬁcients of the NBD-labeled
peptides to the phospholipid vesicles were estimated from the slope
of the binding isotherms. NBD-labeled H-88, Mu1-H-88 and Mu2-H-
88 exhibited an appreciable afﬁnity for PC/Chol lipid vesicles and the
calculated partition coefﬁcients were 1.50 (±0.1)×104, 1.29 (±0.1)×104
and 1.02 (±0.1)×104 M−1 respectively. The nature of the binding
isotherms also provides an idea about the assembly of a peptide in
membrane. The binding isotherms of NBD-labeled mutants in PC/Chol
lipid vesicles weremostly linear in nature (Fig. 2C), suggesting that the
binding of these peptides to PC/Chol vesicles was a simple adhesion
process and no large aggregates of the peptide was formed. However,
the binding isotherm of NBD-labeled H-88 in PC/Chol vesicles bent
downward appreciably and deviated from linearity. As suggested
earlier, this kind of curve indicates the co-operativety in binding of
peptides to membrane [19,25,46]. Thus, the binding isotherms
revealed that only NBD-labeled H-88 but not the mutant formed
large aggregates in zwitterionic lipid vesicles.
3.2. Both H-88 and its mutants adopted signiﬁcant helical structure in
membrane mimetic environments
The secondary structures of the peptides were determined with
the help of their CD spectra in the membrane-mimetic environment,
1% SDS and in the helix stabilizing 40% TFE (v/v) in water. All the
peptides displayed CD spectra with minima at 208 and 222 nm,
characteristic of α-helical secondary structure as shown in Fig. 3. The
mean residual ellipticity values at 222 nm of the CD spectra of H-88 in
40% TFE and 1% SDS were 25,257 and 20,771 which corresponded to
77% and 62% helical structures respectively. For Mu1-H-88 mean
residue ellipticity values at 222 nm in 40% TFE and 1% SDSwere 20,556
and 15,262 which were equivalent to helicities of 62% and 44%
respectively. The Mu2-H-88 exhibited mean residue ellipticity values
Fig. 3.Determination of secondary structures of wild type H-88, Mu1-H-88 andMu2-H-
88 in SDSmicelles (1% w/v) and TFE/water (40% v/v) by recording their CD spectra in the
corresponding environment. Symbols: squares, H-88, circles, Mu1-H-88 and triangles,
Mu2-H-88. Closed symbols represent the spectra in 40% TFE and open symbols
represent the spectra in 1% SDS. The concentrations of H-88, Mu1-H-88 and Mu2-H-88
were 16.3, 16.2 and 14.4 μM respectively.
Fig. 2. Detection of binding and binding afﬁnity of H-88, Mu1-H-88 and Mu2-H-88 to
different kinds of phospholipid membrane by employing their NBD-labeled analogs. (A)
The recording of the ﬂuorescence emission spectra of NBD-labeled H-88 and its mutants
in the absence and presence of the phospholipid vesicles in PBS. Squares, round boxes
and triangles represent H-88, Mu1-H-88 and Mu2-H-88 respectively. Open symbols,
0.20 μM of NBD-labeled peptides in PBS; plus centered symbols, NBD-labeled peptides
in the presence of 412 μM of PC/PG and Closed symbols, NBD-labeled peptides in the
presence of 412 μM of PC/Chol lipid vesicles. (B) Plots of ﬂuorescence of NBD-labeled
H-88, Mu1-H-88 and Mu2-H-88 with increasing amount of PC/Chol lipid vesicles as
marked by lipid/peptide molar ratio. (C) Binding isotherms of NBD-H-88, NBD-Mu1-H-
88 and NBD-Mu2-H-88 in PC/Chol vesicles. The concentrations of the NBD-labeled
peptides were ﬁxed at 0.20 μM and ﬂuorescence values at 527 nm were monitored.
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corresponded to the helix contents of 38% and 36.7%. The CD data
suggest that the substitution of valine or glycine and valine by aspartic
acid to some extent reduced the helical structure of the peptide
derived from the putative transmembrane segment.
3.3. The H-88 peptide containing the putative transmembrane domain in
the tail region of hemolysin E assembled in phospholipid membrane
In order to look into the possibility of an involvement of this
putative transmembrane segment in the assembly of hemolysin E,
energy transfer experiments of H-88 and its mutants were performed
with their NBD- and Rho-labeled analogs that have been employed as
energy donor and acceptor respectively. It is to be mentioned that theshape of the binding isotherms can detect only large aggregates but
not the self-association of a polypeptide to form small sized bundles
[26]. Appreciable energy transfer from an NBD-labeled donor peptide
to a Rho-labeled acceptor one occurs when they are in close proximity
to each other. Fig. 4A shows the typical proﬁles of energy transfer
experiments when increasing amounts of Rho-labeled H-88 were
added to membrane-bound (zwitterionic PC/Chol) NBD-labeled H-88.
It is very much evident that donor's ﬂuorescence progressively
decreased as a result of increase in acceptor's concentration,
suggesting self-association between H-88 peptide molecules in the
zwitterionic lipid vesicles. Also, a signiﬁcant ﬂuorescence energy
transfer was observed between NBD- and Rho-labeled H-88 peptide
molecules when they were bound to the negatively charged PC/PG
lipid vesicles (proﬁles not shown, data presented in Fig. 4C). However,
when Rho-H-88 was replaced with Rho-labeled H-88 mutants or a
rhodamine labeled scrambled peptide (Rho-Scr-198) derived from the
amino acid region 198–234 of HlyE, no signiﬁcant decrease in NBD-H-
88 ﬂuorescence was observed (proﬁles not shown), which indicated
that the H-88 peptide molecules self-assembled in the phospholipid
vesicles with a sequence speciﬁcity. In another control experiment
instead of Rho-H-88 increasing amount of unlabeled H-88 was added
to the membrane-bound (either PC/PG or PC/Chol vesicles) NBD-H-88.
However, ﬂuorescence of NBD-H-88 was unchanged (proﬁles not
shown) indicating that the decrease in NBD-H-88 ﬂuorescence in the
presence of Rho-H-88 in phospholipid vesicles occurs due to energy
transfer fromNBD-labeled peptide to Rho-labeled peptide but not due
to non-speciﬁc aggregation of NBD-labeled peptide molecules. Very
similar energy transfer experiments were also performed with NBD-
and Rho-labeled mutant peptides. Interestingly, the decrease in NBD-
ﬂuorescence as a result of ﬂuorescence energy transfer was much less
in case of Mu1-H-88 (proﬁles not shown but data presented in Fig. 4C)
or Mu2-H-88 (Fig. 4B) when they were bound to the PC/Chol vesicles
indicating that the mutants didn't assemble appreciably in the
zwitterionic membrane. Similar results were obtained when the
mutants were bound to the negatively charged PC/PG lipid vesicles
and therefore proﬁles are not presented but the data are shown in Fig.
4C. In order to further check whether the observed energy transfer
was due to the assembly of the peptide molecules or not, the
percentages of energy transfer with different pairs of energy donor
and acceptor were compared with that of the randomly distributed
energy donor and acceptor as reported earlier [19,26,33,47]. Fig. 4C
clearly indicates that the energy transfer efﬁciencies between NBD-H-
Fig. 4. Determination of self-assembly of H-88 and its mutants by studying the
ﬂuorescence energy transfer experiments with NBD-labeled donor and Rho-labeled
acceptor peptide in the presence of lipid vesicles. The spectra were recorded with the
donor peptide alone and in the presence of varying concentrations of acceptor peptide
with excitation wavelength set at 467 nm. (A) The spectrum of NBD-H-88 (0.15 μM) in
PC/Chol (412 μM) lipid vesicles alone (solid) and with 0.075 μM of Rho-H-88, (dash);
0.150 μM of Rho-H-88, (dot) and 0.225 μM of Rho-H-88, (dash dot) respectively. (B) The
spectrum of NBD-Mu2-H-88 (0.15 μM) in the presence of 412 μM of PC/Chol lipid
vesicles alone (solid) and with various concentrations of Rho-Mu2-H-88; (dash),
0.125 μM; (dot), 0.250 μM and (dash dot), 0.375 μM respectively. (C) Plots of percentages
of experimental energy transfers of different pairs and theoretical energy transfer
corresponding to the randomly distributed donor and acceptor molecules (dotted line)
with respect to the molar ratio of bound acceptor and lipid. Closed symbols for energy
transfer experiments in PC/Chol and open symbols in PC/PG. Symbols: squares, H-88,
circles, Mu1-H-88 and triangles, Mu2-H-88.
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the level of energy transfer that takes place when a donor acceptor
randomly comes close to each other just due to Brownian motion.
However, energy transfer efﬁciencies between NBD-Mu1-H-88 and
Rho-Mu1-H-88 and NBD-Mu2-H-88 and Rho-Mu2-H-88 in zwitter-
ionic or negatively charged vesicles were either below or only
marginally above the random distribution level indicating much
weaker self-association. The results further suggest that the substitu-tion of the conserved valine or glycine and valine by single or double
aspartic acid residues signiﬁcantly disturbed the assembly of the
segment containing the putative transmembrane region in phospho-
lipid membrane.
3.4. H-88but not themutant peptides formedpores in phospholipid vesicles
The segment, involved with the pore-forming activity of the toxin
is not known. In order to detect any possible contribution of this
segment to the pore-forming activity of HlyE, peptide-induced calcein
release from the calcein entrapped zwitterionic and negatively
charged lipid vesicles were examined in the presence of H-88 and
its mutants. Panels A, B and C of Fig. 5 show the typical proﬁles of
calcein release experiments with increasing concentrations of H-88,
Mu1-H-88 and Mu2-H-88 respectively in zwitterionic PC/Chol lipid
vesicles. An increase in ﬂuorescence after the addition of a peptide to
calcein-entrapped lipid vesicles was observed when the dilution of
the probe occurs as a result of its release through the pores formed by
the peptide. Appreciable increase in ﬂuorescence was detected in a
very short time (∼60 s) in the presence of increasing amount of H-88
indicating that the peptide containing the putative transmembrane
segment can trigger the release of liposome-encapsulated calcein in a
concentration-dependent manner probably by forming pores in PC/
Chol lipid vesicles. However, the mutant peptides were almost
inactive as evident from the negligible increase in calcein ﬂuorescence
after its addition. The pore-forming activity of H-88 and its mutants
has been expressed in terms of the percentage of ﬂuorescence
recovery induced by the individual peptides (Fig. 5D). H-88 also
induced the release of calcein in a dose-dependent manner from the
calcein entrapped PC/PG vesicles, which indicates the pore-forming
activity of the peptide in the negatively charged lipid vesicles
(Supplementary Fig. 4). However, like in the zwitterionic lipid vesicles
the mutants Mu1-H-88 and Mu2-H-88 were signiﬁcantly less active
than the wild type H-88 (Supplementary Fig. 4) in the negatively
charged lipid vesicles also. NBD- and Rho-labeled H-88 peptide also
induced appreciable calcein release (∼90% of the unlabeled peptide)
from the calcein-entrapped zwitterionic or negatively charged lipid
vesicles (data not shown) as its unlabeled version suggesting that the
labeling of this peptide didn't have signiﬁcant effect on its functional
activity. Altogether the results indicate the pore-forming activity of
the peptide derived from the putative transmembrane segment in the
tail region but not its mutants in the lipid vesicles.
3.5. H-88, the peptide containing the putative trans-membrane segment
of hemolysin E, exhibited lytic activity towards the human red blood cells
Hemolysin E exhibits cytotoxic activity. It can lyse red blood cells
from a variety of species including human. In order to look into the
possibility of involvement of H-88 segment in the cytotoxic activity of
HlyE, hemolytic activity of H-88 and the designed mutants against the
hRBCs was examined. As shown in Fig. 6A, H-88 exhibited appreciable
hemolytic activity towards human red blood cells. While H-88 showed
∼60% hemolytic activity at ∼8 μM, the mutants (Mu1-H-88 and Mu2-
H-88) did not exhibit any appreciable activity. Also the hemolytic
activity of the peptides H-205, H-198, H-167, H-179, H-130 and H-115,
derived from the protein of the amino acid region 205–234, 198–234,
167–197, 179–209, 130–157 and 115–136 respectively were checked,
which didn't show any detectable activity (data not shown). Since H-
88 (molecular weight 3678 Da) exhibited 50% hemolytic activity at
∼7.2 μM, one hemolytic unit for this peptide corresponded to 26.5 μg.
Thus the speciﬁc activity of H-88 was about 38 hemolytic units/mg
against human red blood cells. However, the speciﬁc activity of
hemolysin E was reported to be ∼200 hemolytic units/mg against
horse red blood cells [9]. Considering the activity of HlyE against
hRBCs is ∼70% to that of horse red blood cells, [11] the activity of H-88
is only ∼ one forth of the whole protein as measured in hemolytic
Fig. 6. Determination of hemolytic activity and the size of the pores formed by H-88 in
human red blood cells. (A) Dose-dependent hemolytic activity of H-88, Mu1-H-88 and
Mu2-H-88 against human red blood cells. Symbols: solid squares, H-88, solid circles,
Mu1-H-88 and solid triangles, Mu2-H-88. (B) The sizes of H-88 induced pores on
human red blood cells were estimated by an osmotic protection assay as described in
the experimental section. Hemolytic activity of H-88 against hRBCs treated with
different osmotic protectors as marked are plotted. For the column H-88, hRBCs were
not treated with any osmotic protector.
Fig. 5. Determination of pore-forming activity of the peptide as examined by the
calcein release induced by H-88, Mu1-H-88 and Mu2-H-88 across the calcein-
entrapped zwitterionic PC/Chol lipid vesicles. (A) Proﬁles of the calcein release
induced by H-88 at different concentrations. The concentrations of H-88 for a to f are
0.06, 0.12, 0.18, 0.3, 0.6 and 1.2 μM respectively. (B) Proﬁles of calcein release induced
by Mu1-H-88 across the PC/Chol vesicles at 1.2 (a), 2.4 (b) and 3.6 (c) μM respectively.
(C) Proﬁles of calcein release induced by Mu2-H-88 across the PC/Chol vesicles at 1.7
(a), 3.4 (b) and 5.1 (c) μM respectively. Peptides were added to the calcein-entrapped
vesicles at time point 1. (D) The relative pore-forming activity of the peptides was
determined by the plots of calcein-ﬂuorescence recovery induced by H-88 and its
mutants with respect to peptide to lipid molar ratio. The concentration of PC/Chol was
2.5 μM and maximum ﬂuorescence intensities were recorded within 60 s of the
addition of the peptides. Symbols: closed squares, H-88, closed circles, Mu1-H-88 and
closed triangles, Mu2-H-88.
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the whole protein, its sequence speciﬁc hemolytic activity probably
points towards an involvement of this segment in HlyE in maintainingthe cytotoxic activity of protein. To the best of our knowledge this is
the ﬁrst report on the hemolytic activity of a peptide derived from
hemolysin E.
3.6. H-88 formed pores of diameter of 2.5–3.4 nm on human red
blood cells
Osmotic protectors are often employed in order to determine the
size of the pores formed by the peptides/proteins on red blood cells
[36,37,48]. As shown in Fig. 6B, sucrose, rafﬁnose, andPEG1450 showed
insigniﬁcant effect on the hemolytic activity ofH-88 tohRBCs.However,
an inhibition of hemolytic activity of H-88 occurred in the presence of
PEG-2000 (diameter 2.5 nm), which was further pronounced in the
presence of PEG-3000 (diameter 3.2 nm). PEG-3350 (diameter 3.4 nm)
caused the maximum inhibition of hemolytic activity of H-88. The
results suggest a probable porediameterof 2.5–3.4nm inducedbyH-88
on the human red blood cells.
When the mixture of PEGs (2000, 3000 and 3350) and hRBC was
washed with PBS to remove the PEGs and the human red blood cells
were further incubated with H-88, the hemolytic activity of the
peptide was observed. The data indicated that PEG-2000, 3000 and
3350 acted just as osmotic protectors but not as the inhibitors of
binding of the peptide to hRBC membrane.
3.7. The same mutations done in the H-88 peptide also signiﬁcantly
affected the toxicity of whole HlyE
It was also investigated how the mutations, which totally
abrogated the hemolytic activity of H-88 peptide inﬂuence the
Fig. 7. Panel A: Alignment of Mu1-HlyE and Mu2-HlyE after converting their
experimental nucleotide sequences into the corresponding protein sequence with
wild type HlyE from a.a. 80–100. Mutated amino acids are underlined. Panel B:
Puriﬁcation of hemolysin E and its mutants from the corresponding GST fusion protein.
The bands in the left lane correspond to molecular weight markers. Lanes 1, 2 and 3 are
respectively the puriﬁed HlyE (1.5 μg), Mu1-HlyE (1.2 μg) and Mu2-HlyE (1.0 μg) after
the cleavage of the corresponding GST fusion protein by thrombin and passing through
GSH-Sepharose column. Panel C shows the dose-dependent hemolytic activity of
hemolysin E and its mutants against the hRBCs. Symbols: open squares, HlyE, open
circles, Mu1-HlyE and open triangles, Mu2-HlyE.
Fig. 8. Damage of membrane organization of human red blood cells in the presence of
H-88 or HlyE and their mutants. The dot plot of the Annexin-V-FITC stained hRBCs in
the absence of any peptide and in the presence of ∼1% DMSO that was used for
solubilization of the peptides (panel A); in the presence of 4.3 μM of H-88 (panel B); in
the presence of 4.3 μM of Mu1-H-88 (panel C); in the absence of any protein (panel D);
in the presence of 0.8 μM HlyE (panel E); in the presence of 0.8 μM of Mu1-HlyE (panel
F). Ten thousands events were counted for each experiment.
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gst-hlyE plasmid was kindly provided by Prof. Jefrey Green, University
of Shefﬁeld, U.K. Site directed mutagenesis was performed in order
make gst-hlyE constructs having the desired mutations. The over
expression and puriﬁcation of hemolysin E and the two mutant
proteins from the fusion protein GST-hemolysin E was achieved as
described earlier [18]. Fig. 7A, shows the puriﬁed HlyE and its two
mutant proteins' bands after GST-HlyE cleavage by thrombin and
passing through GSH-Sepharose column. Hemolytic activity of the
HlyE and two mutant proteins were measured in a similar way as
the H-88 peptides. Fig. 7B shows that hemolytic activity of both the
mutants with single and double amino acid substitutions were
drastically reduced as compared to the activity of wild type HlyE.
Thus the data suggested that these mutations not only affected the
hemolytic activity of the 33-residue H-88 peptide but also abrogated
the hemolytic activity of the whole protein. This signiﬁcant reduction
in the hemolytic activity of HlyE as a result of double and single amino
acid substitution in the putative transmembrane segment probably
raise the possibility of a role of this segment in the toxic activity of
protein.
3.8. Hemolysin E and H-88 but not the mutant proteins or peptides
induced the damages in the membrane organization of human red
blood cells
In order to further look into the cytotoxic activity of H-88 and the
effect of the amino acid substitution on the cytotoxicity of both the
peptide and protein against human red blood cells, annexin V-FITC
staining of hRBCs after the treatment of these peptides and proteinswere carried out. Hemolysin E altered the membrane organization of
hRBCs as evident by the signiﬁcant staining of the cells after
hemolysin E treatment (Fig. 8B) as was reported earlier also [21].
Interestingly, hRBCs was also appreciably stained by annexin V-FITC
after the treatment of the wild type H-88 indicating the ability of the
peptide to damage the membrane organization of the cells (Fig. 8E).
However, when the cells were treated with either of the mutant
proteins or peptides staining of the hRBC decreased appreciably as
compared to their wild type counter parts (Fig. 8, panels C and F). The
data suggested that mutations signiﬁcantly impaired the ability of H-
88 or HlyE to damage the membrane organization of human red blood
cells. Since mutant HlyE or Mu2-H-88 with two amino acid
substitutions exhibited similar activity as the single mutant, the data
of only single mutant was presented.
3.9. Mutations either in HlyE or H-88 signiﬁcantly affected their
permeability toward the human red blood cells
Hemolysin E is a pore-forming toxin and our previous experi-
ments suggested that H-88 forms pores in lipid vesicles. Therefore, in
order to investigate why the mutant proteins or peptides exhibit
signiﬁcantly reduced hemolytic activity as compared to their wild
type counter part, the peptide and protein induced permeability of
Fig. 9. Dose dependent transmembrane depolarization of human red blood cells induced by H-88, HlyE and their mutants as plotted by the percentage of ﬂuorescence recovery vs.
peptide/protein concentrations. In panel A, a, b and c show the representative proﬁles of hRBC membrane depolarization at 7.7 μM concentration of H-88, Mu1-H-88 and Mu2-H-88
respectively; while in panel C, a, b and c show the representative proﬁles for that of HlyE, Mu1-HlyE and Mu2-HlyE at 0.8 μM concentration each. Panel B shows the plot of
ﬂuorescence recovery vs. peptide concentration for H-88 and its mutants whereas panel D depicts the plot of ﬂuorescence recovery vs. protein concentration for HlyE and the
mutants. Panel B-symbols: solid squares, H-88; solid circles, Mu1-H-88 and solid triangles, Mu2-H-88 whereas for panel D symbols: open squares, HlyE; open circles, Mu1-HlyE and
open triangles, Mu2-HlyE.
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the peptides and proteins to dissipate the diffusion potential across
the hRBC membrane was determined by a standard procedure. As
shown in the panels A to D of Fig. 9 both H-88 and HlyE induced
signiﬁcant membrane depolarization in hRBCs indicating their ability
to permeabilize these cell membranes. However, both mutant
peptides and proteins induced comparatively much less depolariza-
tion of the hRBC membrane showing a signiﬁcant effect of these
mutations on the ability of either HlyE or H-88 to permeabilize the
human red blood cells.
4. Discussion
The results depict the characterization of a 33-residue wild type
peptide (H-88), which contains the putative transmembrane segment
(a.a. 89–101) [13] in the tail region of E. coli toxin hemolysin E and two
mutated peptides of the same size. The results also showed the effect
of the same mutations done in the H-88 peptide on the cytotoxic
activity of hemolysin E. The data showed that the wild type peptide
bound to both zwitterionic and negatively charged phospholipid
vesicles (Fig. 2), self-assembled (Fig. 4) and formed pore therein
(Fig. 5). Interestingly, the H-88 peptide also permeabilized hRBC
membrane (Fig. 9), and importantly lysed them (Fig. 6). However,
signiﬁcant changes were observed in the properties of the synthetic
H-88 segment following the substitutions of glycine and valine
residues at 88th and 89th positions respectively to aspartic acid
residues. Even the substitution of only valine to aspartic acid residue
at 89th position caused the similar results. The mutant peptides
although bound to phospholipid vesicles assembled weakly in the
lipid vesicles, did not form pores in the lipid vesicles (Fig. 5) or human
red blood cells (Fig. 9) and also exhibited no lytic activity to the hRBCs
(Fig. 6). Interestingly, the two puriﬁed mutant proteins with double
amino acid substitutions as well as the point mutation exhibiteddramatically reduced cytotoxic activity towards the human red blood
cells (Fig. 7) as was observed in case of the H-88 peptide. Annexin V-
FITC staining of hRBCs following the treatment of the cells with
peptides and proteins showed that mutations either in HlyE or H-88
signiﬁcantly abrogated their ability to damage the membrane
organization of these cells (Fig. 8). It is to be mentioned that according
to a previous report [9] although the intact bacteria bearing G88V89D
HlyE exhibited negligible hemolytic activity, the sonicated bacteria
showed ∼25% activity as compared to the bacteria having the wild
type hlyE plasmid. However, as mentioned already in our experiments
performed with the puriﬁed proteins having the mutations of the
same amino acids exhibited insigniﬁcant hemolytic activity. The
reasons behind these differences in the activity are not clear although
the differences in the experimental procedures could contribute in it.
Considering the surface charge of outer leaﬂet of eukaryotic/
human red blood cell membrane and bacterial membrane, experi-
ments were performed with zwitterionic, PC/Chol and negatively
charged, PC/PG lipid vesicles respectively. Experiments with NBD-
labeled analogs clearly suggested that although H-88 and both the
mutants bound to zwitterionic or negatively charged phospholipid
vesicles (Fig. 2), only the wild type peptide but not the mutants self-
assembled therein. This is to mention that H-88 exhibited partition
coefﬁcient of the same order of magnitude as other well known
membrane-active cytotoxic peptides like paradaxin and melittin. For
example, paradaxin in PC/Chol (9:1 w/w) lipid vesicles exhibited a
partition coefﬁcient of 3.3±0.4×104 [25], while melittin in PC/PG (9:1
w/w) and in DMPC (dimyristoyl phosphatidylcholine) lipid vesicles
exhibited partition coefﬁcients of 4.5±0.6×104 and 6.0×104 respec-
tively [32,49].
H-88 not only formed pores in the zwitterionic lipid vesicles but
also depolarized hRBC membrane (Fig. 9) indicating towards a
probable role of the H-88 segment in the target cell membrane
interaction and cytotoxic activity of hemolysin E. However, the most
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Both the mutants were totally inactive in lysing the human red blood
cells. Equally interesting observation was the drastic reduction in the
cytotoxic activity of the whole protein as a result of the same amino
acid substitutions in it as in the peptide (Fig. 7). Even a point mutation
done in the putative transmembrane segment of the tail region of HlyE
showed dramatic effect on its hemolytic activity against the hRBC as
was observed in case of the double amino acid substitutions. Detailed
structural characterization of the HlyE and its mutants will be
performed separately. However, the result presented here indicated
that these amino acid substitutions impaired the HlyE-induced
depolarization of hRBC membrane or HlyE-induced damage of
membrane organization of hRBC (Figs. 8 and 9), which could result
in the loss of its hemolytic activity against these cells. The results of
the H-88 peptide and the effect of mutations in HlyE together
probably suggest a role of the amino acid segment 88–120, which
contains the putative transmembrane segment of the tail region in the
toxic activity of the protein.
Also the peptides derived from the several other amino acid
regions like 115–136, 130–157, 167–197, 179–209, 205–234 and 198–
234were not at all active probably pointing out that hemolytic activity
of hemolysin E originates from a speciﬁc segment(s) of the protein. It
is to be mentioned that amino acid regions 115–136, 130–157 and
205–234 mostly comprise amphipathic sequences; the 167–197 and
179–209 segments consist of mainly hydrophobic amino acids derived
from the β-tongue region, which overlaps with the other putative
transmembrane domain of hemolysin E while 198–234 segment
contains a leucine zipper motif and a part of β-tongue region. Similar
to the hemolysin E-derived H-88, hemolytic activity of a peptide
derived from the RTX family toxin alpha hemolysin was reported
earlier [50]. However, since H-88 exhibited only ∼ one fourth activity
(measured in hemolytic unit/mg) of the whole protein, it probably
indicates the direct or indirect involvement of other segments also in
maintaining the lytic activity of hemolysin E against the human red
blood cells and/or differences in the folding of H-88 peptide with HlyE
therein. Considering the wide difference in the molecular weights of
H-88 and HlyE, their hemolytic activity have been expressed in terms
of hemolytic activity units per milligram. Hemolytic activity assay
with osmotic protectors revealed that the diameter of the H-88
induced pore on hRBCs was ∼2.5–3.4 nm. It is to be mentioned that
the electron microscopic studies [17] proposed a mean pore size of
5.0 nm diameter for hemolysin E while studies with osmotic
protectors suggested a pore-diameter of 2.5 to 3.0 nm [7,9,10]. It is
not known how H-88 forms pores of diameter of 2.5–3.4 nm on the
hRBCs, which was close to that of HlyE, when determined from the
osmotic protection assays. However, there are pore-forming peptide
and small protein, which form pores of diameter in the similar range
on erythrocyte membrane or on lipid vesicles. For example, melittin, a
26-residue bee venom peptide, has been reported to form pores of
diameter ∼2.0–3.0 nm in erythrocytes [51] and 1.3–2.4 nm [52] and
2.5–3.0 [53] in lipid vesicles while amoebapore A, a 77-residue protein
from protozoan parasite Entamoeba histolytica, forms pores of
diameter 1.3–2.2 nm on lipid bilayer [54].
One of the unique characteristics of this protein-toxin is the
presence of two putative transmembrane domains [9,13,17]. Accord-
ing to the crystal structure [17] one of them is located near the head
region and the other is located in the opposite pole, i.e. in the tail
region. Recently, a peptide corresponding to an amphipathic leucine
zipper like motif near the head region of HlyE has been shown to bind
to both zwitterionic and negatively charged phospholipid vesicles
[19]. Taking into account that H-88, derived from the tail region of
HlyE binds to phospholipid vesicles, it is evident that HlyE possesses
membrane-interacting segments in both of its poles like that is found
in case of the enveloped virus fusion proteins. However, implications
of the presence of membrane-interacting segments in both the poles
of HlyE are not clear. It is interesting to note that a pointmutation evenat the N-terminal of the H-88 peptide (Mu1-H-88) signiﬁcantly
impaired the assembly, pore-forming and hemolytic activity of the
peptide. Also a critical look at the amino acid sequence of the whole
peptide reveals the presence of more hydrophobic amino acids at the
N-terminal of the peptide as compared to its C-terminal. Thus
probably the results suggest a role of the N-terminal hydrophobic
stretch of H-88 segment in its pore-forming lytic assembly.
In the proposed model of hemolysin E pore by Wallace et al., [17]
the individual protein molecule assembles in oligomers with minor
conformational change. However, the very recent models of oligo-
meric HlyE-pore complex are associated with large structural
changes in the ClyA monomer [55,56]. The precise membrane-
interacting or pore-forming segment(s) of hemolysin E is not clearly
known, though the proposed models indicate that the β-tongue
region of HlyE could be the lipid-interacting segment [55,56]. The H-
88 segment under the present investigation comprises the hydro-
phobic putative transmembrane segment from the tail region is one
of the segments that has the potential to interact with the target cell
membrane [9,13]. In the recently proposed model [55] of ClyA pore,
the signiﬁcant increase in its total length and structural change will
put this segment in a pole of hemolysin E, thus making it more
compatible for membrane-interaction.
Site-directed mutagenesis [9] studies showed the loss of activity of
HlyE following the mutation in the β-tongue of the molecule
indicating a crucial role of this segment in the molecule. However, it
is not clear whether these mutations directly affect the activity of the
pore-forming segment of HlyE or alter the conformation of the
protein, which could also impair the toxic activity of the protein. As
mentioned before that our studies indicated that two peptides (H-167
and H-179) with overlapping sequences containing the β-tongue
region didn't show any lytic activity towards human red blood cells.
An extended leucine zipper peptide (H-198) with addition of a small
part of the transmembrane domain-2 (TM-2) although permeabilized
the zwitterionic lipid vesicles better than its shorter version but did
not exhibit any lytic activity toward the hRBCs [20]. Probably, all the
membrane-interacting segments of HlyE may not have the primary
amino acid sequence to lyse a target cell although could participate in
the interaction with the target cell membrane and/or assembly there
in. There aremany such instances in the literature. For example, in case
of viral fusion proteins only a small segment is involvedwith the direct
fusion event with the target cell membrane but there are other
important segments like heptad repeats which play crucial role in
maintaining fusogenic conformation andmembrane interaction of the
molecule [57–59]. Site directedmutagenesis in both the fusion peptide
as well as heptad repeat regions equally affect the fusogenic activity of
the protein. The present observations on the ability of H-88 segment to
permeabilize and lyse the human red blood cells with sequence
speciﬁcity could argue in favor of a direct role of the amino acid
segment 88–120 in the cytotoxic activity of HlyE against these cells.
5. Conclusion
This report depicts a detailed characterization of an important
segment of HlyE by studies on both synthetic peptides and the whole
protein. In summary, the results suggest that probably the amino acid
segment (a.a. 88–120) containing the putative transmembrane
segment of the tail region could play an important role in maintaining
the toxic activity and/or interaction with target cell membrane of
HlyE. The mutations done in the putative transmembrane segment of
the protein also abrogated the hemolytic activity of the toxin, which
further strengthens a plausible role of this segment in the cytotoxic
activity of the protein. Perhaps, the homologous segments in the other
toxins of hemolysin E family may also play important structural and
functional roles. Also, the results support the growing notion that it is
possible to identify a small segment from a membrane-protein, which
exhibits a functional activity of the whole protein at least partly.
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